Position in LLY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,196,200
-$463,085 QoQ
Shares Held
3,475
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. LLY ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,631 | $3,331,961 | |
| 2 | NVS |
Novartis AG
|
21,135 | $3,228,371 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,475 | $3,196,200 | |
| 4 | GSK |
GSK plc
|
42,695 | $2,356,337 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,029 | $1,955,221 | |
| 6 | MRK |
Merck & Co., Inc.
|
14,018 | $1,686,225 | |
| 7 | ABBV |
AbbVie Inc.
|
6,748 | $1,467,622 | |
| 8 | NVO |
Novo Nordisk A S
|
31,948 | $1,174,089 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,196,200 | 3,475 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,659,285 | 3,405 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,477,461 | 3,247 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $2,511,645 | 3,222 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $2,683,381 | 3,249 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $3,964,992 | 5,136 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $4,641,439 | 5,239 | Shares | Sole | 2024-12-10 | |
| 2024-06-30 | $4,426,402 | 4,889 | Shares | Sole | 2024-12-10 | |
| 2024-03-31 | $2,003,247 | 2,575 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,123,286 | 1,927 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,040,957 | 1,938 | Shares | Sole | 2024-01-30 | |
| 2023-06-30 | $798,203 | 1,702 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $522,685 | 1,522 | Shares | Sole | 2023-06-16 | |
| 2022-12-31 | $570,344 | 1,559 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $466,594 | 1,443 | Shares | Sole | 2023-02-21 | |
| 2022-06-30 | $432,847 | 1,335 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $369,990 | 1,292 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $344,170 | 1,246 | Shares | Sole | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||